Fidson Healthcare Plc (NGX:FIDSON)

Nigeria flag Nigeria · Delayed Price · Currency is NGN
90.00
0.00 (0.00%)
At close: Feb 27, 2026
354.55%
Market Cap 216.00B
Revenue (ttm) 119.06B
Net Income (ttm) 9.31B
Shares Out 2.40B
EPS (ttm) 3.88
PE Ratio 23.20
Forward PE 13.21
Dividend 1.00 (1.11%)
Ex-Dividend Date Jul 14, 2025
Volume 674,067
Average Volume 1,181,987
Open n/a
Previous Close 90.00
Day's Range n/a
52-Week Range 17.05 - 95.50
Beta 0.81
RSI 70.92
Earnings Date Mar 27, 2026

About Fidson Healthcare

Fidson Healthcare Plc manufactures and distributes pharmaceutical products in Nigeria. The company operates in three segments: Over-the-Counter, Ethical Products, and Consumer Healthcare Product. It offers drugs, infusions, and injectables. The company also provides products for anti infective and anti malaria, central nervous system, and cough and cold, gastrointestinal medicines; supplements; topical/dermatological medicines; vitamins and minerals; and ophthalmic solutions. Fidson Healthcare Plc was incorporated in 1995 and is headquartered i... [Read more]

Industry Pharmaceutical Preparations
Founded 1995
Employees 674
Stock Exchange Nigerian Stock Exchange
Ticker Symbol FIDSON
Full Company Profile

Financial Performance

In 2025, Fidson Healthcare's revenue was 119.06 billion, an increase of 41.42% compared to the previous year's 84.19 billion. Earnings were 9.31 billion, an increase of 61.05%.

Financial Statements

News

There is no news available yet.